Critical Pharmaceuticals door

Lisbeth Illum Joins as CEO

Lisbeth Illum Joins as CEO 10/01/2007 03:35

Lisbeth Illum Joins as CEO

Critical Pharmaceuticals Limited today announced that Professor Lisbeth Illum has been appointed Chief Executive Officer. Chairman of the Board, Dr Alan Raymond said, “Professor Illum brings with her years of experience in commercialising innovative drug delivery technologies, and we look forward to benefiting from her expert guidance and leadership.”

Lisbeth Illum was the founder and for 12 years the Managing Director of DanBioSyst UK Ltd. and for 3 years the Managing Director of Phaeton Research Ltd. both companies that specialised in Drug Delivery Systems. She is also associated with Nottingham University as a Special Professor. She was awarded her M. Pharm, Ph. D and D.Sc. from the Royal Danish School of Pharmacy in 1972, 1978 and 1988, respectively. She is a world renowned scientist in the field of novel drug delivery systems for difficult drugs such as peptide and proteins. She has published more than 300 scientific papers, and is among the top 100 most cited scientists in the field of pharmacology. She has co-edited four books including "Peptide Drug Delivery Systems" published by Plenum Press, 1986, and has filed nearly fifty patents on novel drug delivery systems. She has been awarded the title of "Docent" in the Royal Danish School of Pharmacy and has been the recipient of several scientific awards. She has been elected a Fellow of the AAPS and is the Vice-President of the Controlled Release Society. She has lectured throughout the world at conferences and workshops. She is on the Editorial Boards of seven scientific journals. She joins Critical Pharmaceutical as the CEO on her extensive business and managing experience from running small drug delivery companies.

CriticalMix Technology

CriticalMix rig

CriticalMix enables the manufacture of highly active sustained release depot products for bimonthly, monthly or less frequent injection.

Read more

CriticalSorb Technology

nasal device

CriticalSorb enables the non-invasive nasal delivery delivery of high-value biologic products and challenging small molecule drugs.

Read more

Dr Alan Raymond, Critical Pharmaceuticals
“Professor Illum brings with her years of experience in commercialising innovative drug delivery technologies, and we look forward to benefiting from her expert guidance and leadership.”